论文部分内容阅读
近日,关于同仁堂的“一泡舒保健足浴液”批准文号问题的争议闹得沸沸扬扬并上了法庭。原告刘殿林认为,“一泡舒保健足浴液”的批准文号——京卫健字(2001)002号早已被停止使用和自行作废,同仁堂鸿日药业涉嫌法人造假;而被告同仁堂则表示,作为保健类外用产品的“一泡舒保健足浴液”不需要批文。目前双方各执一词,正在等待法院的第二次开庭。
Recently, the controversy over Tong Ren Tang’s approval of the issue of a “bubble bath” was uproar and went to court. Plaintiff Liu Dianlin believes that “a bubble Shu health foot bath” approval number - Beijing Weijianzi (2001) 002 has long been discontinued and self-defeating, Tong Ren Tang Hong Ri Pharmaceutical alleged fraud; and the defendant Tong Ren Tang said, As a topical health care products, “a bubble Shu health foot bath” does not require approval. At present, both parties are holding their own terms and are waiting for the second court hearing.